148547-50-6Relevant articles and documents
5-HT RECEPTOR MODULATORS
-
Paragraph 0562; 0563, (2013/03/26)
The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
Synthesis of potent and selective serotonin 5-HT1B receptor ligands
Huang, Yiyun,Bae, Sung-A.,Roth, Bryan L.,Laruelle, Marc
, p. 4786 - 4789 (2007/10/03)
A series of serotonin 5-HT1B ligands were synthesized and evaluated for their potency and selectivity against other 5-HT receptor subtypes. Many of these new compounds displayed high affinity and selectivity for the 5-HT1B receptor a